You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
偉思醫療(688580.SH):2023年年度淨利潤預增40%到50%
格隆匯 01-17 17:00

格隆匯1月17日丨偉思醫療(688580.SH)公佈2023年年度業績預吿,經財務部門初步測算,公司預計2023年年度實現營業收入人民幣45,100.00萬元到48,100.00萬元,與上年同期(法定披露數據)相比,將增加12,937.86萬元到15,937.86萬元,同比增加40%到50%。

預計2023年年度實現歸屬於母公司所有者的淨利潤為13,100.00萬元到14,100.00萬元,與上年同期(法定披露數據)相比,將增加3,717.41萬元到4,717.41萬元,同比增加40%到50%。預計2023年年度實現剔除股份支付費用影響後的歸屬於母公司所有者的淨利潤為14,600.00萬元到15,500.00萬元,與上年同期(法定披露數據)相比,將增加5,266.26萬元到6,166.26萬元,同比增加56%到66%。

預計2023年年度實現歸屬於母公司所有者的扣除非經常性損益的淨利潤為11,500.00萬元到12,250.00萬元,與上年同期(法定披露數據)相比,將增加3,840.93萬元到4,590.93萬元,同比增加50%到60%。

報吿期內,公司堅持研發創新驅動,持續擴展產品管線,經營規模實現穩步提升,業務結構逐漸優化改善。其中全新一代盆底功能磁、經顱磁、團體生物反饋儀等產品實現迭代升級上市,市場競爭力顯著增強,自上市以來,以磁刺激為代表的核心產品業務規模與市場份額快速增長,收穫市場終端的積極反饋。同時,報吿期內公司營銷體系在完成優化調整後,整體團隊執行力及終端覆蓋度進一步提升,疊加康復醫療市場需求不斷增加,促使公司報吿期內取得積極銷售成果。後續公司將進一步加強市場開拓和渠道建設,加快推進在研項目取證進度,以期營業收入和淨利潤保持健康良好增長態勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account